US Stock MarketDetailed Quotes

GANX Gain Therapeutics

Watchlist
  • 1.560
  • -0.010-0.64%
Close Dec 20 16:00 ET
  • 1.550
  • -0.010-0.64%
Post 20:01 ET
41.38MMarket Cap-1.46P/E (TTM)

Gain Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-53.18%-6.08M
-14.64%-5.76M
14.96%-3.59M
-28.41%-18.87M
-44.97%-5.66M
-20.60%-3.97M
0.59%-5.02M
-72.32%-4.22M
-18.81%-14.69M
5.83%-3.9M
Net income from continuing operations
4.93%-4.49M
-5.92%-8.14M
21.86%-4.01M
-26.59%-22.27M
-1.06%-4.72M
-3.51%-4.72M
-51.18%-7.69M
-56.98%-5.14M
-26.64%-17.59M
-45.17%-4.67M
Depreciation and amortization
5.53%21.64K
1.75%20.59K
6.68%20.53K
30.25%83.58K
30.25%23.59K
15.04%20.51K
1.09%20.24K
134.40%19.24K
314.41%64.17K
212.89%18.11K
Other non cash items
74.18%-44.18K
-462.31%-166.13K
-63.74%-200.15K
-85.24%-383.19K
3.74%-135.7K
-377.36%-171.11K
--45.85K
---122.24K
-506.01%-206.86K
-1,892.18%-140.97K
Change In working capital
-37,071.39%-1.93M
-23.37%1.05M
-8.89%416.81K
-70.81%442.23K
-512.96%-1.38M
-100.56%-5.18K
624.31%1.37M
-10.39%457.47K
559.35%1.51M
124.14%334.02K
-Change in receivables
----
----
----
-3,682.15%-130.07K
----
----
----
----
105.73%3.63K
----
-Change in prepaid assets
-121.74%-39.33K
-202.43%-403.3K
45.70%-298.47K
249.17%174.39K
-44.40%149.37K
-62.52%180.92K
13.36%393.74K
54.79%-549.64K
76.64%-116.91K
148.60%268.66K
-Change in payables and accrued expense
-3,920.98%-1.85M
318.79%1.48M
-33.47%703.59K
-160.29%-643.16K
-109.23%-976.79K
-115.34%-46.1K
-32.87%-677.85K
-39.33%1.06M
304.59%1.07M
73.71%-466.85K
-Change in other current liabilities
----
----
----
-107.11%-50.53K
----
----
----
----
6.85%711.07K
----
-Change in other working capital
76.81%-32.47K
-101.84%-30.43K
123.14%11.68K
829.45%1.09M
-1,131.70%-371.34K
-3,266.10%-140K
1,781.46%1.65M
-196.73%-50.47K
-266.22%-149.65K
30.07%-30.15K
Cash from discontinued investing activities
Operating cash flow
-53.18%-6.08M
-14.64%-5.76M
14.96%-3.59M
-28.41%-18.87M
-44.97%-5.66M
-20.60%-3.97M
0.59%-5.02M
-72.32%-4.22M
-18.81%-14.69M
5.83%-3.9M
Investing cash flow
Cash flow from continuing investing activities
-100.00%-1
-34.25%2M
43.27%3.02M
169.19%10.22M
2,247.65%3.14M
17,002.33%1.93M
120.45%3.05M
27,026.26%2.11M
-15,582.52%-14.77M
1,305.89%133.83K
Net PPE purchase and sale
99.85%-1
-491.30%-21.55K
--0
87.09%-15.36K
99.80%-19
98.86%-650
91.82%-3.64K
-41.15%-11.05K
-26.26%-118.95K
15.32%-9.4K
Net investment purchase and sale
--0
-33.62%2.02M
42.53%3.02M
169.86%10.24M
2,093.62%3.14M
4,115.55%1.93M
120.54%3.05M
--2.12M
---14.66M
--143.23K
Cash from discontinued investing activities
Investing cash flow
-100.00%-1
-34.25%2M
43.27%3.02M
169.19%10.22M
2,247.65%3.14M
17,002.33%1.93M
120.45%3.05M
27,026.26%2.11M
-15,582.52%-14.77M
1,305.89%133.83K
Financing cash flow
Cash flow from continuing financing activities
501.37%808.68K
356.75%10.04M
-119.47%-145.8K
16,147.61%12.64M
44,398.94%9.56M
753.38%134.47K
161,115.26%2.2M
2,072.16%748.91K
-100.19%-78.77K
-121.69%-21.58K
Net issuance payments of debt
-2.15%-23.12K
0.61%-22.11K
-5.83%-22.87K
-13.07%-89.07K
-4.62%-22.58K
-9.96%-22.63K
-1,732.13%-22.25K
43.09%-21.61K
-258.86%-78.77K
1.68%-21.58K
Net common stock issuance
429.46%831.79K
352.55%10.04M
--0
--12.73M
--9.58M
--157.1K
--2.22M
--770.52K
--0
--0
Proceeds from stock option exercised by employees
--1
--13.58K
--157.94K
----
----
--0
--0
--0
----
----
Net other financing activities
--0
--0
---280.87K
----
----
----
----
----
----
----
Cash from discontinued financing activities
Financing cash flow
501.37%808.68K
356.75%10.04M
-119.47%-145.8K
16,147.61%12.64M
44,398.94%9.56M
753.38%134.47K
161,115.26%2.2M
2,072.16%748.91K
-100.19%-78.77K
-121.69%-21.58K
Net cash flow
Beginning cash position
167.14%16.97M
77.31%10.67M
61.10%11.83M
-80.11%7.34M
-60.55%4.3M
-55.69%6.35M
-82.49%6.02M
-80.11%7.34M
391.88%36.91M
-73.40%10.91M
Current changes in cash
-176.73%-5.27M
2,741.25%6.28M
47.59%-713.64K
113.53%4M
285.69%7.04M
42.68%-1.9M
101.11%221.11K
45.39%-1.36M
-200.81%-29.55M
8.99%-3.79M
Effect of exchange rate changes
364.77%382.81K
-88.21%13.12K
-1,251.69%-442.5K
2,152.38%488.4K
113.78%483.25K
-36.43%-144.58K
217.72%111.31K
177.91%38.42K
-123.61%-23.8K
250.42%226.05K
End cash Position
180.77%12.08M
167.14%16.97M
77.31%10.67M
61.10%11.83M
61.10%11.83M
-60.55%4.3M
-55.69%6.35M
-82.49%6.02M
-80.11%7.34M
-80.11%7.34M
Free cash flow
-53.15%-6.08M
-14.98%-5.78M
15.18%-3.59M
-27.48%-18.88M
-44.62%-5.66M
-18.56%-3.97M
1.39%-5.03M
-72.22%-4.23M
-18.87%-14.81M
5.86%-3.91M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -53.18%-6.08M-14.64%-5.76M14.96%-3.59M-28.41%-18.87M-44.97%-5.66M-20.60%-3.97M0.59%-5.02M-72.32%-4.22M-18.81%-14.69M5.83%-3.9M
Net income from continuing operations 4.93%-4.49M-5.92%-8.14M21.86%-4.01M-26.59%-22.27M-1.06%-4.72M-3.51%-4.72M-51.18%-7.69M-56.98%-5.14M-26.64%-17.59M-45.17%-4.67M
Depreciation and amortization 5.53%21.64K1.75%20.59K6.68%20.53K30.25%83.58K30.25%23.59K15.04%20.51K1.09%20.24K134.40%19.24K314.41%64.17K212.89%18.11K
Other non cash items 74.18%-44.18K-462.31%-166.13K-63.74%-200.15K-85.24%-383.19K3.74%-135.7K-377.36%-171.11K--45.85K---122.24K-506.01%-206.86K-1,892.18%-140.97K
Change In working capital -37,071.39%-1.93M-23.37%1.05M-8.89%416.81K-70.81%442.23K-512.96%-1.38M-100.56%-5.18K624.31%1.37M-10.39%457.47K559.35%1.51M124.14%334.02K
-Change in receivables -------------3,682.15%-130.07K----------------105.73%3.63K----
-Change in prepaid assets -121.74%-39.33K-202.43%-403.3K45.70%-298.47K249.17%174.39K-44.40%149.37K-62.52%180.92K13.36%393.74K54.79%-549.64K76.64%-116.91K148.60%268.66K
-Change in payables and accrued expense -3,920.98%-1.85M318.79%1.48M-33.47%703.59K-160.29%-643.16K-109.23%-976.79K-115.34%-46.1K-32.87%-677.85K-39.33%1.06M304.59%1.07M73.71%-466.85K
-Change in other current liabilities -------------107.11%-50.53K----------------6.85%711.07K----
-Change in other working capital 76.81%-32.47K-101.84%-30.43K123.14%11.68K829.45%1.09M-1,131.70%-371.34K-3,266.10%-140K1,781.46%1.65M-196.73%-50.47K-266.22%-149.65K30.07%-30.15K
Cash from discontinued investing activities
Operating cash flow -53.18%-6.08M-14.64%-5.76M14.96%-3.59M-28.41%-18.87M-44.97%-5.66M-20.60%-3.97M0.59%-5.02M-72.32%-4.22M-18.81%-14.69M5.83%-3.9M
Investing cash flow
Cash flow from continuing investing activities -100.00%-1-34.25%2M43.27%3.02M169.19%10.22M2,247.65%3.14M17,002.33%1.93M120.45%3.05M27,026.26%2.11M-15,582.52%-14.77M1,305.89%133.83K
Net PPE purchase and sale 99.85%-1-491.30%-21.55K--087.09%-15.36K99.80%-1998.86%-65091.82%-3.64K-41.15%-11.05K-26.26%-118.95K15.32%-9.4K
Net investment purchase and sale --0-33.62%2.02M42.53%3.02M169.86%10.24M2,093.62%3.14M4,115.55%1.93M120.54%3.05M--2.12M---14.66M--143.23K
Cash from discontinued investing activities
Investing cash flow -100.00%-1-34.25%2M43.27%3.02M169.19%10.22M2,247.65%3.14M17,002.33%1.93M120.45%3.05M27,026.26%2.11M-15,582.52%-14.77M1,305.89%133.83K
Financing cash flow
Cash flow from continuing financing activities 501.37%808.68K356.75%10.04M-119.47%-145.8K16,147.61%12.64M44,398.94%9.56M753.38%134.47K161,115.26%2.2M2,072.16%748.91K-100.19%-78.77K-121.69%-21.58K
Net issuance payments of debt -2.15%-23.12K0.61%-22.11K-5.83%-22.87K-13.07%-89.07K-4.62%-22.58K-9.96%-22.63K-1,732.13%-22.25K43.09%-21.61K-258.86%-78.77K1.68%-21.58K
Net common stock issuance 429.46%831.79K352.55%10.04M--0--12.73M--9.58M--157.1K--2.22M--770.52K--0--0
Proceeds from stock option exercised by employees --1--13.58K--157.94K----------0--0--0--------
Net other financing activities --0--0---280.87K----------------------------
Cash from discontinued financing activities
Financing cash flow 501.37%808.68K356.75%10.04M-119.47%-145.8K16,147.61%12.64M44,398.94%9.56M753.38%134.47K161,115.26%2.2M2,072.16%748.91K-100.19%-78.77K-121.69%-21.58K
Net cash flow
Beginning cash position 167.14%16.97M77.31%10.67M61.10%11.83M-80.11%7.34M-60.55%4.3M-55.69%6.35M-82.49%6.02M-80.11%7.34M391.88%36.91M-73.40%10.91M
Current changes in cash -176.73%-5.27M2,741.25%6.28M47.59%-713.64K113.53%4M285.69%7.04M42.68%-1.9M101.11%221.11K45.39%-1.36M-200.81%-29.55M8.99%-3.79M
Effect of exchange rate changes 364.77%382.81K-88.21%13.12K-1,251.69%-442.5K2,152.38%488.4K113.78%483.25K-36.43%-144.58K217.72%111.31K177.91%38.42K-123.61%-23.8K250.42%226.05K
End cash Position 180.77%12.08M167.14%16.97M77.31%10.67M61.10%11.83M61.10%11.83M-60.55%4.3M-55.69%6.35M-82.49%6.02M-80.11%7.34M-80.11%7.34M
Free cash flow -53.15%-6.08M-14.98%-5.78M15.18%-3.59M-27.48%-18.88M-44.62%-5.66M-18.56%-3.97M1.39%-5.03M-72.22%-4.23M-18.87%-14.81M5.86%-3.91M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Heat List
US
Overall
Symbol
Price
% Chg

No Data